Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for perioperative neurocognitive disorder prevention in thoracic surgery
ChiCTR1900023596Phase 4Not yet recruiting
- Sponsor
- Chengd Shangjin Nanfu Hospital, West China Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in perioperative neurocognitive disorder and post-operative cognitive decline (POCD) (2 arms), sponsored by Chengd Shangjin Nanfu Hospital, West China Hospital. Primary endpoint: Incidence of postoperative cognitive dysfunction. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
perioperative neurocognitive disorderpost-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR1900023596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023596.